Literature DB >> 20814843

Evaluation of a mass measles vaccination campaign among school children aged 7-14 years old in Denizli, Turkey.

A I Bozkurt1, M Bostanci, N Cevahir, Ahmet Ergin, I Sancak, B Yilmaz, B Çatak.   

Abstract

OBJECTIVE: To determine the pre-campaign level of measles seropositivity and to evaluate the effect of a mass measles vaccination campaign on measles seroposivity among primary school children in Denizli, Turkey.
METHODS: The study was completed in two socioeconomically different areas of Denizli, Turkey, with a sample size of 520 students. One primary school from each area and one classroom from each grade were randomly included in the sample. Before and 2-months after the measles mass vaccinations, blood samples were collected from the students and measles specific IgGs were studied.
RESULTS: The pre-campaign overall seropositivity was 74.7%. Post-campaign overall seropositivity increased to 96.5%. Pre-campaign seropositivity among 8-graders was significantly lower than that in other grades (57.5%, p<0.001) and the difference was explained by the number of vaccinations 8-graders received. Except for the number of vaccination doses, other factors did not have any effect on seropositivity.
CONCLUSIONS: The mass measles vaccination programs have a potential to control measles for developing countries. In addition, more than one dose of measles vaccination is required for developing countries.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20814843     DOI: 10.1007/s12098-010-0124-z

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  8 in total

1.  Measles IgG seroprevalence prior to mass vaccination in Taiwan.

Authors:  Min-Shi Lee; D James Nokes; Ying-Chang Wu; Yao-Hsiung Huang; Chih-Feng Lu
Journal:  Int J Infect Dis       Date:  2002-03       Impact factor: 3.623

2.  Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.

Authors:  Daniel A Kertesz; Kandjoura Touré; Adama Berthé; Youssouf Konaté; Flabou Bougoudogo
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

3.  Difficulties in measles elimination: prevalence of measles antibodies before and after mass vaccination campaign in Laos.

Authors:  Chushi Kuroiwa; Phoxay Xayyavong; Phengta Vongphrachanh; Bouaphan Khampapongpane; Miki Yamanaka; Satoshi Nakamura
Journal:  Vaccine       Date:  2003-01-17       Impact factor: 3.641

4.  Measles seroprevalence in Izmir with special emphasis on measles vaccination policy for Turkey.

Authors:  A Egemen; S Aksit; T Ozacar; Z Kurugol; P Keskinoglu; T Pehlivan; S Mutlu
Journal:  Pediatr Int       Date:  2001-08       Impact factor: 1.524

5.  Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997.

Authors:  M S Lee; L J Chien; Y Y Yueh; C F Lu
Journal:  Vaccine       Date:  2001-09-14       Impact factor: 3.641

6.  Impact of mass measles campaigns among children less than 5 years old in Uganda.

Authors:  Miriam Nanyunja; Rosamund F Lewis; Issa Makumbi; Rachel Seruyange; Eva Kabwongera; Possy Mugyenyi; Ambrose Talisuna
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

7.  Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.

Authors:  Kathryn A Kohler; Ali Jaffer M Suleiman; Susan E Robertson; Pradeep Malankar; Saleh Al-Khusaiby; Rita F Helfand; David Brown; William J Bellini; Roland W Sutter
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

8.  Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.

Authors:  Adriana Pistol; Karen Hennessey; Daniela Pitigoi; Nicolae Ion-Nedelcu; Emilia Lupulescu; Laura Walls; William Bellini; Peter Strebel
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.